Combination therapy of inhibitors of epidermal growth factor receptor/vascular endothelial growth factor receptor 2 (AEE788) and the mammalian target of rapamycin (RAD001) offers improved glioblastoma tumor growth inhibitionRanjit K. Goudar, Jeremy N. Rich, Roger E. McLendon et al.|Molecular Cancer Therapeutics|2005Cited by 245
Secreted Protein Acidic, Rich in Cysteine (SPARC), Mediates Cellular Survival of Gliomas through AKT ActivationQing Shi, Jeremy N. Rich, Shideng Bao et al.|Journal of Biological Chemistry|2004Cited by 116